Emilien Gregoire

Dr. Emilien Gregoire

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2021 in Pathogens
Verified
Journal Article
Open access
PDF file
EGEmilien Gregoire
Emilien Gregoire
BPBenoit François Pirotte
Benoit François Pirotte
FMFilip Moerman
Filip Moerman
AAAntoine Altdorfer
Antoine Altdorfer
LGLaura Gaspard
Laura Gaspard
GDGilles Darcis
Gilles Darcis
Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) is an increasingly recognized complication of COVID-19 and is associated with significant over-mortality. We performed a retrospective monocentric study in patients admitted to the intensive care unit (ICU) for respiratory insufficiency due to COVID-19 from March to December 2020, in order to evaluate the incidence of CAPA and the associated risk factors. We also analysed the diagnostic approach used in our medical centre for CAPA diagnosis. We defined CAPA using recently proposed consensus definitions based on clinical, radiological and microbiological criteria. Probable cases of CAPA occurred in 9 out of 141 patients included in the analysis (6.4%). All cases were diagnosed during the second wave of the pandemic. We observed a significantly higher realization rate of bronchoalveolar lavage (BAL) (51.1% vs. 28.6%, p = 0.01) and Aspergillus testing (through galactomannan, culture, PCR) on BAL samples during the second wave (p < 0.0001). The testing for Aspergillus in patients meeting the clinical and radiological criteria of CAPA increased between the two waves (p < 0.0001). In conclusion, we reported a low but likely underestimated incidence of CAPA in our population. A greater awareness and more systematic testing for Aspergillus are necessary to assess the real incidence and characteristics of CAPA.

1 January 2021 in IDCases
Verified
Journal Article
Open access
AAAntoine Altdorfer
Antoine Altdorfer
BPBenoit F. Pirotte
Benoit F. Pirotte
LGLaura Gaspard
Laura Gaspard
EGEmilien Gregoire
Emilien Gregoire
EFEric Firre
Eric Firre
MMMarcella Mori
Marcella Mori
We present a case of infective endocarditis (IE) on a prosthetic pulmonary valve in a 36-year-old patient with tetralogy of Fallot (TOF). The patient underwent valve replacement surgery and active antibiotic treatment against Gram-negative cocci (Piperacillin Tazobactam then Ceftriaxone) for a total duration of 42 days with a favourable outcome. The causative agent was Neisseria mucosa which was identified on the infected valve by sequencing of 16S ribosomal RNA. To our knowledge, this is the first described case of a N. mucosa infective endocarditis on a pulmonary valve. Initially, serologies performed in clinical settings by immunofluorescence for Coxiella burnetii antibodies showed a major increase in phase I IgG titers at 1024 (normal values <16) corresponding with the diagnostic criteria for Q fever endocarditis. However, this diagnosis could not be confirmed by the National Reference Center, making it the first reported case of a false positive serology for C. burnetii during an infection due to Neisseria spp.

22 April 2021 in Acta Clinica Belgica
Verified
Journal Article
Closed access
EGEmilien Gregoire
Emilien Gregoire
BPBenoit François Pirotte
Benoit François Pirotte
FMFilip Moerman
Filip Moerman
AAAntoine Altdorfer
Antoine Altdorfer
LGLaura Gaspard
Laura Gaspard
GDGilles Darcis
Gilles Darcis
Opportunistic infections (OI) are common in patients with acquired immunodeficiency syndrome (AIDS). Cryptococcus neoformans and Mycobacterium avium complex (MAC) are frequently responsible of such...